WeightWatchers said Tuesday it is filing for Chapter 11 bankruptcy protection to eliminate $1.15 billion in debt and focus on its transition...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Wegovy® will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark, the largest Pharma...

The recent advancements in the treatment of liver diseases, particularly metabolic dysfunction-associated steatohepatitis (MASH) and non-alc...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug...

The compounded versions of the drug were originally sold to combat a brand-name shortage

Target has announced it will reduce bonuses for salaried employees due to weak consumer spending and inflationary pressures. Read more...

Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharma...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or compounded, versio...

Novo Nordisk said Thursday that the rampant growth of the U.S.' compounded drug industry was hurting Wegovy sales, and warned it was conside...

"Mounjaro’s been great," the comedian said in an Instagram video. "I’m having a really good experience with it and I wanted to keep it real...

Amy Schumer had some positive praise for Mounjaro after a not-so-great experience with Wegovy years prior.“Three years ago, I tried Wegovy,...

There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, manage obstructi...

Weight loss drugs are already taking a bite out of many people’s wallets. Read More

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who can’t get the blo...